NCT05501587 Measures of Respiratory Health Registry
| NCT ID | NCT05501587 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of British Columbia |
| Condition | Respiratory Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2018-10-11 |
| Primary Completion | 2028-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2018-10-11 with a primary completion date of 2028-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
There are many techniques that can allow for the quantification of lung function in children; some are being used clinically and others are under development. Many of these tools are available at BC Children's Hospital. This registry study will act as a central repository for the results of traditional and novel pulmonary function tests done at BC Children's Hospital to allow for future analysis.
Eligibility Criteria
Participants with CF Inclusion Criteria: -Diagnosis of CF as evidenced by one or more clinical feature consistent with the CF phenotype or positive CF newborn screen AND one or more of the following criteria: i. A documented sweat chloride ≥ 60 mEq/L by quantitative pilocarpine iontophoresis (QPIT). ii. A documented genotype with two disease-causing mutations in the CFTR gene. \- In the opinion of the investigator, the participant will likely have the ability to perform the lung function test of interest on the day of testing Exclusion Criteria: * Physical findings at the screening that would compromise the safety of the participant or the quality of the data (e.g. respiratory distress or work of breathing) * Requirement of supplementary oxygen to maintain oxygen saturation above 95% Participants with other Respiratory Disease Inclusion criteria: * Physician-diagnosed lung disease * Informed consent by participant, parent, or legal guardian * In the opinion of the investigator, the participant will likely have the ability to perform the lung function test of interest on the day of testing Exclusion criteria * Physical findings at screening that would compromise the safety of the participant or the quality of the research data * Requirement of supplementary oxygen to maintain oxygen saturation above 95% Healthy Participants * Inclusion criteria * Informed consent by participant, parent, or legal guardian * In the opinion of the investigator, the participant will likely have the ability to perform the lung function test of interest on the day of testing Exclusion criteria * Physical findings at screening that would compromise the safety of the participant or the quality of the research data * Evidence of lung disease
Contact & Investigator
Jonathan Rayment, MDCM, MSc
PRINCIPAL INVESTIGATOR
University of British Columbia
Frequently Asked Questions
Who can join the NCT05501587 clinical trial?
This trial is open to participants of all sexes, aged 0 Years or older, up to 99 Years, studying Respiratory Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05501587 currently recruiting?
Yes, NCT05501587 is actively recruiting participants. Contact the research team at Rodrigo.Sandoval@bcchr.ca for enrollment information.
Where is the NCT05501587 trial being conducted?
This trial is being conducted at Vancouver, Canada.
Who is sponsoring the NCT05501587 clinical trial?
NCT05501587 is sponsored by University of British Columbia. The principal investigator is Jonathan Rayment, MDCM, MSc at University of British Columbia. The trial plans to enroll 1,000 participants.